Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
40 studies found for:    " September 21, 2011":" October 21, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" September 21, 2011":" October 21, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Terminated A Phase I Safety and Immunogenicity Preventive Vaccine Trial Based on the HIV-1 Tat and V2-deleted Env Proteins (ISS P-002)
Condition: HIV Infection
Interventions: Biological: HIV-1 Tat/delta-V2 Env combined vaccine;   Biological: HIV-1 delta-V2 Env vaccine;   Biological: HIV-1 Tat vaccine 7.5 microg;   Biological: HIV-1 Tat vaccine 30 microg
2 Unknown  Early Antiviral Therapy for Critically Ill HIV Infected Patients
Condition: HIV Infection
Interventions: Drug: early HAART;   Drug: Late HAART
3 Unknown  RAltegravir Switch STudy: Effects on Endothelial Recovery
Conditions: HIV Infection;   Endothelial Dysfunction
Intervention: Drug: raltegravir
4 Completed A Commitment Device for Medication Adherence Among HIV Patients
Conditions: Acquired Immunodeficiency Syndrome;   HIV
Intervention: Other: Medication Adherence among HIV/AIDS Patients
5 Completed
Has Results
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Interventions: Drug: COBI;   Drug: DRV;   Drug: NRTIs
6 Completed
Has Results
Human Immunodeficiency Virus (HIV) Postexposure Prophylaxis (PEP) With Darunavir/Ritonavir (DRV/r)
Condition: Human Immunodeficiency Virus (HIV)
Interventions: Drug: Darunavir/Ritonavir (DRV/r);   Drug: Lopinavir in fixed combination with Ritonavir;   Drug: Zidovudine;   Drug: NRTIs;   Drug: Efavirenz
7 Terminated
Has Results
A Study of the Neurological Effects of Adding Raltegravir to HAART Regimen in Patients With HIV
Conditions: Human Immunodeficiency Virus (HIV);   HIV Associated Neurocognitive Disorders (HAND)
Intervention: Drug: Raltegravir
8 Completed
Has Results
A Study of the Neurological Effects of Adding Maraviroc to HAART Regimen in Patients With HIV (HANDmac)
Conditions: Human Immunodeficiency Virus (HIV);   HIV Associated Neurocognitive Disorders (HAND)
Intervention: Drug: Maraviroc
9 Unknown  Dimiracetam in Painful Neuropathies Affecting AIDS Patients
Condition: Acquired Immunodeficiency Syndrome
Interventions: Drug: Dimiracetam;   Drug: Dimiracetam 25 mg
10 Completed Correlates of Oral Human Papillomavirus Infection in Adolescents and Young Adults With Behaviorally Acquired HIV
Condition: HIV Infection
Intervention:
11 Completed A Study on Antiretroviral Therapy (ART) Naïve Patients On Different Regimens to Treat Hiv (NORTHIV)
Condition: HIV
Interventions: Drug: Lopinavir ritonavir;   Drug: Atazanavir ritonavir;   Drug: Efavirenz
12 Active, not recruiting Management of Hepatitis C in HIV Infected Injection Drug Users (IDUs)
Conditions: HIV Infection;   Hepatitis C
Intervention: Behavioral: Contigent voucher incentive
13 Completed Maternal-fetal CD4 Microchimerism in HiV Exposed Newborns After Spontaneous Delivery and Cesarean Section
Condition: Human Immunodeficiency Virus
Intervention:
14 Unknown  Video-Based Delivery of HIV Test Information for Spanish-Speaking Latinos
Conditions: HIV;   AIDS
Intervention: Behavioral: Video or In-Person Presentation
15 Completed
Has Results
Influence of Antiretroviral Regimen on Immune Reconstitution in the Female Genital Tract
Conditions: Women's Health;   HIV Infection;   Genital Diseases, Female
Intervention:
16 Completed Culturally Sensitive Intervention to Improve Retention in HIV Care for Latino MSM
Condition: HIV
Intervention: Behavioral: Peer Navigator Intervention
17 Completed Comparative Tolerability of Protease Inhibitors
Condition: HIV
Intervention:
18 Active, not recruiting
Has Results
Dolutegravir Compared to Darunavir/Ritonavir , Each in Combination With Dual Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in ART-naive Subjects
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: dolutegravir 50 mg OAD;   Drug: darunavir 800mg OAD;   Drug: ritonavir 100mg OAD
19 Completed Promoting Male Involvement to Improve Prevention of Mother to Child Transmission (PMTCT) Uptake and Reduce Antenatal Infection
Conditions: HIV;   Pregnancy
Interventions: Behavioral: PartnerPlus Intervention;   Other: Usual Care
20 Withdrawn Evaluating the Safety and Immune Response to Two Pneumococcal Vaccines in HIV-Infected Pregnant Women
Conditions: Pneumococcal Infections;   HIV Infections
Interventions: Biological: PPV-23 Vaccine;   Biological: PCV-13 Vaccine;   Biological: Placebo Vaccine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.